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Abstract Sphingosine-1-phosphate (S1P) is a bioactive lipid
molecule. It stimulates the growth of some cells, but inhibits the
growth of others. In this study, we describe the detection of sub-
WM to WM concentrations of S1P in the ascitic fluids of patients
with ovarian cancer. In ovarian cancer cells cultured in vitro, S1P
exhibited a dual effect on growth and/or survival. S1P (10 WM)
induced cell death when cells were in suspension but stimulated
cell growth when cells were attached. The calcium-dependent
induction of cell death by S1P is apparently associated with its
inhibitory effect on cell attachment and cell adhesion. S1P (10^
30 WM) also induced calcium-dependent cell-cell aggregation.
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1. Introduction
Ovarian malignancies have the worst prognosis of any gy-
necological malignancy, due to the di⁄culty in early detection
and the lack of e¡ective treatment for the metastasized dis-
ease. We have shown that ascitic £uids from patients with
ovarian cancer contain biologically active lipid molecules,
such as lysophosphatidic acid (LPA), which stimulates the
growth of tumor cells [1,2]. We also have shown that LPA
levels are elevated in blood from patients with ovarian cancer
and may represent a useful marker for the early detection of
ovarian cancer [3]. Another bioactive lipid molecule, sphingo-
sine-1-phosphate (S1P), has been shown to stimulate cell pro-
liferation of ¢broblasts and other cell lineages but inhibits
growth of breast cancer cells [4,5]. Low concentrations of
S1P (10^100 nM) inhibit tumor invasion of melanoma cells
through their receptors [6] and 5 WM of S1P inhibits cell in-
vasion of MDA-MB-231 breast cancer cells [4]. S1P (5^20
WM) induces cell-cell aggregation in S1P-receptor (Edg1)-
transfected HEK293 cells through up-regulation of cadherin
molecules [7]. We report here that S1P is present in the ascites
of patients with ovarian cancer and it exhibits a dual e¡ect on
the growth of ovarian cancer cells in vitro: it inhibited growth
and induced cell death if cells were in suspension when S1P
was added but stimulated growth of attached cells. S1P in-
hibited cell attachment to the surface of tissue culture dishes
or adhesion to extracellular matrix (ECM) proteins: laminin,
collagens I and IV and ¢bronectin. S1P also induced cell-cell
aggregation in suspended cells. Our data suggest that S1P is
an important growth and adhesion modulator for ovarian
carcinoma.
2. Materials and methods
2.1. Materials
RPMI 1640 was purchased from Fisher Scienti¢c (Spring¢eld, NJ,
USA). The medium supplement (insulin-transferrin-selenium) was
purchased from GIBCO BRL (Grand Island, NY, USA). Human
plasma ¢bronectin (HFN) and human laminin were from Chemicon
International (Temecula, CA, USA). Human collagens type I and IV
were from Becton Dickinson Labware (Bedford, MA, USA). Fatty
acid free BSA, soybean trypsin inhibitor and MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) were from Sigma (St.
Louis, MO, USA). Antibodies against catenins and integrin L1 were
from Transduction Laboratories (Lexington, KY, USA). BCA protein
assay kit was from Pierce (Rockford, IL, USA). [3H]acetic anhydride
(50 mCi/mmol) was from NEN Life Sciences (Boston, Ma).
2.2. S1P quantitation
Quantitation of S1P from ascitic £uids was performed as described
by Yatomi et al. [8,9]. Brie£y, S1P was extracted from 0.5 ml of
ascites followed by N-acylation with [3H]acetic anhydride. The result-
ing [3H]C2-Cer-1-P (N-[3H]-acetylated S1P) was applied to silica gel
60 TLC plates (EM Science, Gibbstown, NJ, USA) and the plates
were developed in butanol/acetic acid/water (3:1:1). Autoradiography
was performed with Kodak BioMax MS ¢lm using a Kodak BioMax
Transcreen-LE Intensifying Screen (Eastman Kodak, Rochester, NY,
USA). Radioactive spots corresponding to [3H]C2-Cer-1-P were
scraped and radioactivity was measured via liquid scintillation count-
ing. The S1P in the ascites samples was quanti¢ed by extrapolation
from S1P standards that were subjected to the same procedures.
2.3. Cell lines and cell culture
Ovarian cancer cell lines, HEY and OCC1, were kind gifts from Dr.
Gordon Mills’ laboratory (M.D. Anderson). Cells were cultured in
RPMI 1640 with 10% FBS. Starvation was conducted for 24^48 h
in serum-free RPMI 1640. To detach cells, either trypsin-EDTA (GIB-
CO, BRL, Grand Island, NY, USA) or 2 mM EDTA in PBS was
used. Cells were then washed twice with 0.2% soybean trypsin inhib-
itor (if trypsin was used) or RPMI 1640, and resuspended in either
RPMI 1640 or Medium A [Hams F12:DMEM (1:1 v/v), supple-
mented with 0.1% fatty acid free BSA, insulin, transferrin and sele-
nium as recommended by the manufacturer GIBCO BRL (Grand
Island, NY, USA)].
2.4. Cell growth assays
MTT dye reduction was used to measure proliferation as described
previously [10] with some modi¢cations. Brie£y, di¡erent concentra-
tions of reagents (LPA or S1P) in 100 Wl of Medium A were ¢rst
added to each well of a 96-well plate. Starved ovarian cancer cells
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were suspended and added to each well (5U103 cells/100 Wl). Follow-
ing a 72-h incubation at 37‡C, 10 Wl of MTT solution (5 mg MTT/ml
in H2O) was added to each well and incubated at 37‡C for 6 h. After
removal of the supernatant, the dye was dissolved in 100 Wl of etha-
nol/DMSO (1:1, v/v). The absorbance was measured at 595 nm, with
655 nm as the reference wavelength. The growth e¡ect of LPA and
S1P on attached cells was examined by counting the number of living
cells in the presence of trypan blue. Brie£y, HEY cells were cultured
in 24-well plates in RPMI 1640 with 10% FBS and starved in RPMI
without FBS for 48 h. While cells were still attached, the medium was
changed to Medium A. LPA or S1P was added to the ¢nal concen-
trations as indicated. Cells were counted after 72 h incubation at 37‡C
with 5% CO2.
2.5. Cell attachment assays
Starved ovarian cancer cells (HEY or OCC1) were resuspended in
RPMI-1640 without serum and 2 ml of cells (1.3U105 cells/ml) was
added to each well of a 6-well plate. Di¡erent reagents were added
and the cells were incubated at 37‡C. Phase-contrast images were
taken 6 h later. The attached cells and the £oating cells were counted
separately and the percentage of attached cells was calculated by
dividing the number of attached cells by the total cell number (both
attached and £oating living cells).
2.6. Adhesion assays
The adhesion assays were performed as described by Dunn et al.
[10] with modi¢cations. Brie£y, 96-well plates were coated at 4‡C
overnight with laminin (in PBS), collagen I or IV (in acetic acid) or
HFN (in PBS) each at a concentration of 10 Wg/ml. Plates were rinsed
and blocked with heat-denatured fatty acid free BSA (0.02%). S1P or
LPA (100 Wl) at various concentrations was added to each well and
the starved cells [100 Wl HEY or OCC1 resuspended in RPMI 1640
without serum (2U105 cells/ml)] were added to each well and incu-
bated for 2 h at 37‡C. Phase contrast photos were taken and non-
adherent cells were removed by washing with PBS. Cells were ¢xed
and stained with 0.5% crystal violet in 20% MeOH for 10 min at room
temperature. The crystal violet stain was washed with PBS and dis-
solved in 0.1% SDS and the optical absorbance was measured at 595
nm using a microplate reader (SpeedMax 340, Molecular Devices
Corporation, Sunnyvale, CA, USA).
3. Results
3.1. S1P was present in ascites from patients with ovarian
cancer
We have previously detected LPA in ascites from patients
with ovarian cancer and showed that LPA is growth-stimulat-
ing for ovarian tumor cells [1^3]. S1P is a similar bioactive
lipid molecule, stimulating growth of di¡erent cell types [4].
To determine whether S1P plays a patho-/physiological role in
ovarian cancer development, we measured S1P levels in ascites
from seven patients with ovarian cancer, using the method
described by Yatomi et al. [8,9]. Ascitic £uids from all seven
patients contained S1P. The levels of S1P in the ascitic £uids
ranged from 0.42^2.17 WM (Mean þ S.D. = 1.073 þ 0.25).
3.2. S1P displayed a dual e¡ect on the growth/survival of
ovarian cancer cells
The presence of S1P in ascites promoted us to determine the
potential role of S1P in ovarian cancer cells. Interestingly, S1P
displayed a dual e¡ect on the growth of ovarian cancer cells.
When cells were detached with trypsin-EDTA, mixed with
S1P or LPA and replated in tissue culture wells, LPA stimu-
lated, but S1P inhibited cell growth as analyzed using a MTT
dye incorporation method. A narrow concentration range of
S1P (0.5^2 WM) consistently showed a very weak stimulation
(Fig. 1A). However, if cells were allowed to attach before
addition of S1P or LPA, both lipids stimulated cell growth
as analyzed by cell counting, even though S1P was a weaker
mitogen than LPA (Fig. 1B). Since S1P (up to 50 WM) was
not cytotoxic to attached ovarian cancer cells as assessed by
trypan blue exclusion, the inhibitory e¡ect of S1P on sus-
pended cells shown in Fig. 1A may result from the inhibitory
e¡ect of S1P on cell attachment. Similar results were observed
in another ovarian cancer cell line, OCC1.
3.3. S1P inhibited cell attachment and induced cell death
The dual e¡ects described above suggest that S1P may in-
hibit cell attachment. We examined the e¡ect of S1P and
related lipids on cell attachment to the surface of tissue cul-
ture plates. Control cells in RPMI 1640 attached to the sur-
face of tissue culture dishes in a time-dependent manner (1 h,
5%; 3 h, 25%; 6 h, 45% and 20 h, 100%). We found that S1P
(20 WM) strongly inhibited cell attachment, concurrent with
the induction of cell-cell aggregation (Fig. 2c). The inhibitory
e¡ect of S1P was dose-dependent. While 1 WM of S1P was not
Fig. 1. E¡ects of LPA and S1P on cell growth and/or survival of
ovarian cancer cells (HEY). A: LPA or S1P was titrated from 0.07
WM to 50 WM in 96-well plates as triplets. MTT assays were per-
formed as described in Section 2. B: LPA or S1P was added to the
attached cells (HEY) in Medium A to ¢nal concentrations as indi-
cated. Cells were counted after 72 h. Data are mean values þ S.D.
of three separate experiments.
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e¡ective, 5^20 WM of S1P inhibited 20^100% of cell attach-
ment.
Other related lipid molecules at the same concentration (20
WM) displayed di¡erent e¡ects. LPA had some stimulatory
e¡ect (Fig. 2B) compared to control cells (Fig. 2A), sphingo-
sine did not have any detectable e¡ect on cell attachment (Fig.
2E) and sphingosylphosphorylcholine (SPC) inhibited cell at-
tachment, but did not induce cell-cell aggregation (Fig. 2D).
The stimulatory e¡ect of LPA was dose- and time-dependent.
For 5, 10 and 20 WM of LPA, respectively, the percentage of
attached cells was: 1 h: 3, 5, 5%; 3 h: 20, 28, 35%; 6 h: 56,
78, 100%. Detached cells with either trypsin-EDTA or EDTA
alone showed similar results in all cell attachment and adhe-
sion (see below) experiments.
3.4. S1P inhibited cell adhesion
To examine the e¡ect of S1P in a more physiological man-
ner, we determined the e¡ect of LPA or S1P on cell adhesion
to di¡erent ECM proteins. As shown in Fig. 3A and B, LPA
(20 WM) did not signi¢cantly a¡ect cell adhesion to laminin,
collagens I and IV or HFN (P values range from 0.29 to 0.65).
In contrast, S1P (20 WM) signi¢cantly inhibited cellular adhe-
sion to laminin (P = 0.0092) and HFN (P = 0.0033). The in-
hibitory e¡ects of S1P on collagen I and collagen IV were less
signi¢cant (P = 0.0660 and 0.0169, respectively) (Fig. 3A and
B). These e¡ects were dose-dependent. Two types of dose-
dependent curves were observed (Fig. 3C). For collagens I
and IV and laminin, a dual e¡ect of S1P was observed. Curve
a in Fig. 3C represents a typical dose-dependent e¡ect of S1P
on these ECM proteins. S1P from as low as 10 nM to 5 WM
was stimulatory on cell adhesion and 10^50 WM of S1P was
inhibitory. For HFN, a stronger and monophasic inhibition
was observed (Fig. 3C, curve b).
3.5. The cell-death induced by S1P
Apparently, S1P-induced death of resuspended cells (shown
in Figs. 1A and 2C) was associated with its inhibitory e¡ect
on cell attachment. We tested whether prevention of attach-
ment was the main reason for cell death induced by S1P. We
cultured HEY cells in bacterial plates and most of the cells
were not attached, but were viable. When these cells were
replated in tissue culture dishes after 24 h in suspension,
they had the ability to attach and proliferate. In addition,
we cultured HEY cells in Medium A in the presence of 3
mM EGTA, which prevented cells from attaching even after
28 h incubation. At this time point, the control, 20 WM LPA-
treated and 20 WM S1P-treated cells had a similar number of
viable cells, suggesting that S1P-induced cell death is calcium-
dependent. However, when these £oating cells were replated
in RMPI 1640 with 10% FBS after washing with PBS, and
allowed to grow for another 72 h, cells treated with 20 WM
S1P showed 20^30% growth inhibition.
The e¡ect of the incubation time with S1P on cell survival
(in the absence of EGTA) was tested. HEY cells were treated
with 20 WM of S1P and incubated in 6-well plates. At each
time point (0.5, 2.5, 5, 8 and 24 h), cells from three di¡erent
wells were washed twice with RPMI 1640 and replated in the
medium without S1P. The number of cells surviving at 48 h
after initial plating were counted. The survival rates (com-
pared to controls) were: 0.5 h: 40.5%; 2.5 h: 31.4%; 5 h:
10.2%; 8 h: 7.1% and 24 h: 0.86%. The S1P treated cells
tended to be round, small and condensed, which are charac-
teristics of apoptotic cells [11].
3.6. S1P induced cell-cell aggregation
Concurrently with the inhibition of cell attachment, S1P (10
WM) induced cell-cell aggregation reproducibly (Fig. 2C). The
aggregation occurred as early as 2 h after initial incubation
and maximized at approximately 6 h. Addition of 3 mM of
EGTA completely prevented the induction of aggregation by
S1P (data not shown), suggesting that S1P-induced aggrega-
tion is calcium-dependent. Cells in aggregates induced by S1P
were not able to attach even after prolonged incubation and
actually died within a few hours incubation with S1P as as-
sessed by trypan blue exclusion.
3.7. The mechanisms of S1P-induced aggregation, inhibition of
adhesion/attachment and cell death
HEY and OCC1 cells express comparable endogenous
amounts of Edg1 as that of HEK293 (unpublished results).
Overexpression of Edg1 in HEK293 induces cell-cell aggrega-
tion, which is related to upregulation of P- and E-cadherins
[7]. We observed that S1P (10^20 WM) induced cell-cell aggre-
gation in suspended HEY or OCC1 cells without Edg1 over-
expression. Moreover, the expressions of E-, P- and K- cad-
herins were not observed in HEY cells (data not shown),
although the involvement of other forms of cadherins, such
as VE-cadherin or cadherin-5 remains to be tested.
On the other hand, K-, L- and Q-catenins, paxillin and L1
Fig. 2. E¡ects of di¡erent lipids on cell attachment to the plastic
surface of a tissue culture plate (6-well plate). One milliliter of
starved and resuspended HEY cells (2U105 cells/ml) were mixed
with PBS (Control, A), LPA (B), S1P (C), SPC (D) or sphingosine
(E) at a ¢nal concentration of 20 WM, respectively. Cells were incu-
bated in 6-well plates in duplicates and pictures were taken 6 h after
plating.
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Fig. 3. E¡ects of LPA or S1P on cell adhesion to ECM proteins. A 96-well plate was coated with 10 Wg/ml of laminin, collagen I or IV, or
HFN and blocked with denatured fatty acid free BSA (0.02%). Starved HEY cells treated with 20 WM of LPA or S1P (2U104 cells/100 Wl)
were plated in each well. A: Phase contrast photos were taken 3 h later. B: Adherent cells were quanti¢ed by crystal violet staining (Section
2). C: Dose-dependent e¡ect of S1P on cell adhesion. Curve a: The dual e¡ect of S1P on cells (HEY) adhesion to laminin. Curve b: The in-
hibitory e¡ect of S1P on cell adhesion to HFN. The same experimental procedure described in A and B, but using di¡erent concentrations of
S1P, was performed. Data were analyzed by Student’s t test using the GraphPad Instat software (San Diego, CA, USA). P6 0.05 was consid-
ered to be signi¢cant.
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integrin were expressed in HEY cells. While the expression of
K- and L-catenins was una¡ected by LPA or S1P (15 WM for
6 h), paxillin was weakly upregulated (1.2-fold) by both LPA
and S1P and Q-catenin was downregulated (approximately
20%) by S1P (Fig. 4). In addition, the protein expression of
integrin L1 was downregulated (approximately 25%) by 15
WM S1P (3.5 h treatment; data not shown). These data sug-
gest the potential role of Q-catenin and integrin L1 in S1P-
induced aggregation and/or inhibition of cell attachment or
adhesion.
4. Discussion
The dual e¡ects of S1P have been described in several dif-
ferent contexts. Unlike LPA, which has been shown to act
mainly extracellularly as a ¢rst messenger, S1P acts both as
an intracellular second messenger and extracellular ¢rst mes-
senger through its receptors [5,6]. S1P has been shown to
display opposite growth e¡ects on di¡erent cell lines [4]. It
inhibits invasion but not adhesion of melanoma cells at low
concentrations (10^100 nM) using Transwell assays [11,12].
S1P at 5 WM also inhibits invasion of breast cancer cells in
Boyden chambers lined with Matrigel (rich in laminin and
collagen IV) [4], but stimulates invasion of T-lymphoma cells
(1^15 WM of S1P) using a rat embryo ¢broblast monolayer
cell invasion assay [13]. Here, we describe for the ¢rst time
that in the same cells, S1P exhibited dual e¡ects on cell pro-
liferation and/or cell survival, dependent on whether or not
cells are attached. We showed that the inhibitory e¡ect of S1P
on cell growth or survival was apparently associated with its
inhibitory e¡ect on cell attachment or cell adhesion. This as-
sociation is re£ected by both the dose correlations between
growth inhibition and adhesion (Fig. 1A and 3C, curve a)
and structural speci¢city. We have shown that SPC is growth
inhibitory for these ovarian cancer cells [2] and also inhibitory
for cell attachment (Fig. 2). In contrast, LPA stimulated both
growth and attachment. We noted that cells in aggregates died
quickly, but aggregation may not be necessary for cell death,
since SPC-induced cell death was not associated with aggre-
gation. In addition, the degree of aggregation varied from
experiment to experiment, but the inhibition was consistent.
Our results further indicate that the prevention of cell at-
tachment may not be su⁄cient to induce cell death and addi-
tional mechanisms may be involved. We showed that HEY
cells in suspension when cultured in bacterial plates or in the
presence of EGTA can survive for at least 24 h and cells could
reattach and proliferate after removal of EGTA. In contrast,
incubation with 20 WM of S1P for as short as 0.5 h resulted in
the death of the majority of cells (V60% cell death). The
mechanism of S1P-induced cell death is not clear at present.
Our results, however, have provided a few clues, (1) the same
concentration of S1P was growth-stimulatory for attached,
but inhibitory for suspended cells. These results suggest that
the attachment-stimulated cell signalling may be a prerequisite
for the stimulatory e¡ect of S1P; (2) a calcium-dependent
signalling pathway is required for the S1P-induced cell death
in suspended cells, since S1P did not induce cell death until
removal of EGTA. Upon removal of both EGTA and S1P, a
slower growth rate was observed in cells pretreated with S1P,
suggesting that S1P may be internalized during the pre-incu-
bation time.
S1P (5^20 WM) has been shown to induce apoptosis in
human hepatoma cells [14] but inhibit apoptosis or anoikis
(apoptosis when adherent cells are detached or adherence is
inhibited) in human HL60, Jurkat and U937 cells [15^17].
Whether S1P induces apoptosis in ovarian cancer cells re-
mains to be determined.
Sadahira et al. reported that S1P inhibits invasion without
a¡ecting cell adhesion in melanoma cells [12]. However, we
found that S1P at low concentrations (6 1 WM) had either a
stimulatory e¡ect (on laminin, collagens I and IV) or an in-
hibitory e¡ect (on HFN) in ovarian cancer cells. At higher
concentrations (10^20 WM), S1P strongly inhibited cell attach-
ment or cell adhesion to laminin, collagens I and IV and
HFN. At these concentrations, S1P was not cytotoxic in at-
tached HEY or OCC1 cells as assessed by trypan blue exclu-
sion. S1P has also been shown to be non-cytotoxic at high
concentrations (up to 100 WM) in ¢broblasts [4].
Ovarian cancer cells express various adhesion molecules,
such as integrins L1 and L3, and CD44 [18,19]. Integrins KL1
and KL3 bind a wide variety of ECM proteins, of which col-
lagens I and IV, HFN and laminin are known to be produced
by ovarian tumor cells [18,19]. The di¡erent e¡ects of LPA or
S1P on adhesion of ovarian cancer cells described here suggest
that LPA and S1P may regulate integrin molecules di¡erently.
It is unclear at this point whether e¡ects described here are
receptor-mediated. Due to the lack of speci¢c antagonists for
S1P receptors at present, this question has not been addressed
directly. Nevertheless, we tested the requirement for the pres-
ence of S1P in the media to exert its e¡ect. It has been re-
ported that a short incubation time (0.5 h) with S1P, followed
by washing and replacement of media, resulted in 50% of
maximum DNA synthesis induced by 24 h of treatment [4].
This observation, together with other evidence, has been used
to argue that S1P-induced proliferation depends on S1P up-
Fig. 4. The e¡ect of LPA or S1P on protein expression of catenins
and paxillin. HEY cells were suspended with trypsin-EDTA, washed
and seeded in 10-cm tissue culture plates. LPA or S1P was added to
a ¢nal concentration of 15 WM and incubated for 6 h. Cells were
lysed and the protein concentrations were measured using the Pierce
BCA protein assay kit. Equal amounts (30 Wg) of proteins were
loaded on a 8% SDS-PAGE gel. Antibodies against catenins or pax-
illin were from Transduction Laboratories (Lexington, KY, USA)
and anti-L-actin antibody was from Sigma. The ECL detection kit
(Amersham) was used for visualization. Lane 1: Control; lane 2:
LPA (15 WM); lane 3: S1P (15 WM).
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take and is not receptor-mediated [4]. We have conducted a
similar experiment to determine whether the continuous pres-
ence of S1P is necessary for its e¡ect. We showed that S1P
strongly inhibits cellular proliferation (V60%) after a short
incubation time (0.5 h) with cells, supporting the idea that
cells may internalize S1P. On the other hand, the further in-
hibitory e¡ect of S1P on cell survival was dependent on the
presence of S1P in the medium. Increased percentages of the
cells died when the incubation time with S1P increased. Even
at 8 h, the removal of S1P resulted in a 9-fold increase in cell
survival compared to 24 h. These data suggest at least two
possibilities. First, S1P may play a dual e¡ect: both extracel-
lular and intracellular. S1P was not completely internalized
and the presence of S1P in the media is necessary to exert
further inhibition. Therefore, part of the e¡ect of S1P may
be mediated through its receptor(s). Secondly, S1P induced a
secondary factor(s), which was present in the cell media re-
sulting in the further inhibitory e¡ect. Currently, we are un-
able to distinguish between these two possibilities. We found
that both HEY and OCC1 express S1P receptors Edg1 and
Edg3 (authors’ unpublished data). Some receptor-mediated
e¡ect requires WM concentrations of the agonist. For example,
S1P (5^20 WM) induces cell-cell aggregation in S1P-receptor
(Edg1)-transfected, but not the mock-transfected HEK-293
cells, suggesting the e¡ect is receptor-mediated [7].
Preliminary mechanistic studies suggest that ovarian cancer
cells may represent a di¡erent model system from that previ-
ously described for HEK293 cells. S1P (1^20 WM) has been
shown to induce morphological changes in S1P receptor
(Edg1) overexpressed HEK293 cells, but not in the parental
cells [7]. Overexpression of the S1P receptor (Edg1) in
HEK293 cells upregulates P- and E-cadherins, but not cyto-
plasmic cadherin-associated proteins, such as K-, L- and Q-
catenins [7]. In addition, the expression of focal adhesion ki-
nase (FAK) and paxillin in these cells was unaltered by over-
expression of Edg1. In contrast, S1P induced similar aggrega-
tion e¡ects without overexpression of exogenous Edg1 in
HEY ovarian cancer cells. In addition, E-, P-, and N-cadher-
ins were not detected, consistent with the notion that cadher-
ins are down-regulated in metastatic tumor cells [18,20].
Moreover, Q-catenin, paxillin and integrin L1 were regulated
by S1P, although the functional role of these regulations in
S1P-induced cellular e¡ects remains to be examined. Cell-cell
aggregation induced by S1P may involve a di¡erent mecha-
nism in HEK293 cells compared to ovarian cancer cells.
Ovarian tumor cells inherently possess strong invasiveness
to the peritoneum through direct dissemination, rather than
through lymphatic or hematogenous routes [21,22]. This
metastatic potency relies on the ability of tumor cells to de-
tach from the primary site and to attach and subsequently
implant and proliferate in the mesothelium of the peritoneal
cavity. The e¡ect of S1P on growth, attachment, adhesion and
aggregation, which are critically important processes in tumor
cell invasion, suggest that S1P may play a role in ovarian
tumor development and/or metastasis. Importantly, we found
that S1P was present in ascitic £uids from patients with ovar-
ian cancer in sub-WM to WM concentrations, suggesting a
potential pathological role in ovarian cancer. This is in con-
trast to the reports that S1P is absent in ascites [9]. However,
the sources of these ascitic £uids were not speci¢ed [9]. De-
pendent on the concentrations of S1P in ascites and the at-
tachment status of tumor cells, S1P may play a dual or more
complex role in ovarian tumor development and metastasis.
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